FFL Flash Alert - The Eagles WR has been the breakout player of the season. Can he stay hot with Jalen Reagor set to return?
FFL Flash Alert - The Eagles WR has been the breakout player of the season. Can he stay hot with Jalen Reagor set to return?
The U.S. National Highway Traffic Safety Administration (NHTSA) said the two affiliated Korean automakers agreed to consent orders after the agency said they had inaccurately reported some information to NHTSA regarding the recalls. Kia's civil penalty totals $70 million, including an upfront payment of $27 million, requirements to spend $16 million on specified safety measures and a potential $27 million deferred penalty.
Disney has increased the scope of its planned job cuts, and Apple is reportedly diversifying production.
The Asia Pacific medical device additives manufacturing market is expected to reach US$ 8457. 79 million by 2027 from US$ 249. 15 million in 2019; it is anticipated to grow at a CAGR of 16. 8% during 2019–2027.New York, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asia Pacific Medical Devices Additives Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology ; Product, Application and Country" - https://www.reportlinker.com/p05989504/?utm_source=GNW The medical device additives manufacturing market is growing primarily due to high investments and expenditure on healthcare and advancing technologies in manufacturing medical devices, strong presence of key market players and the increasing demand for implants of orthopedic, dental and cochlear applications.Factors such high costs associated to medical device additives manufacturing process damage the growth of the market. Additionally, increasing financial contributions by government and private sector in medical device industries is likely to fuel the growth of the medical device additives manufacturing market during the forecast period. Additive manufacturing is a technique used for manufacturing rapid prototypes as well as functional end-use parts.The use of additive manufacturing in the medical industry has witnessed an accelerating adoption in the recent years owing to various technological advancements such as custom-made medical devices. With additive manufacturing being implied in the healthcare industry, the scope for customization and innovation of medical devices has increased considerably over the last few years. Additive manufacturing is majorly beneficial in medical fields such as production of new orthopedic products, fabrication of customized maxillofacial prostheses, and casting of dental implants.Further, it is also receiving attention as a method used in biomedical modelling and organ printing. The increase in demand for additive manufacturing has encouraged medical device manufacturing companies to invest significantly in the development of commercial models and reduction of the cost of modelling.Leading medical device market players have uniquely positioned themselves to benefit from the advances offered by additive manufacturing. For instance, in May 2018, Medtronic announced development of the TiONIC Technology, which is a new 3D printed technique that helps to build enhanced surface techniques for designing of medical devices. Thus, the increasing demand for the additive manufacturing technology in healthcare, leading to rising investments by market players for its advancement, fuels the growth of the medical device additive manufacturing market. Moreover, in 2017, the ‘Additive Manufacturing Industry Development Action Plan’, announced by Chinese government aimed at making a national AM industry worth US$3 billion by 2020.Further, companies such as UnionTech (one of China’s largest SLA 3D printer manufacturers), INTAMSYS and Farsoon Technologies implementing innovative technologies and offers smarter and efficient production of medical devices additives. The growing geriatric population as well as increasing number of private dental hospital and clinics across the Asia Pacific is expected to be the major factor responsible for the increased demand for dental restoration devices. In 2019, the laser sintering segment accounted for the largest share of the Asia Pacific medical device additives manufacturing market.The growth of the market for this segment attributes to the factors such as advantageous over Stereolithography and other methods and Laser sintering can develop medical devices and its parts with high-precision and geometries that are almost impossible to achieve by other methods. Moreover, the same segment is also likely to register the highest CAGR in the market during the forecast period. In 2019, surgical instruments product segment held the largest share of the market, whereas the implants and prosthetics segment is estimated to register the highest CAGR in the market during the forecast period.The growth of this segment can be attributed to minimum practical barriers, and ease of manufacturing these surgical instruments. Moreover, Additives manufacturing technologies enables manufacturers to develop more personalized, surgeon-specific instruments with significant cost-effectiveness, which is expected to gain major market share for the surgical instruments segment. In terms of application segment, The Orthopedic segment held the largest share of the market in 2019, and same segment is estimated to register the highest CAGR of in the market during the forecast period. Factors such as development of customized orthopedic devices and implants and reduced overall treatment cost are responsible for the growth of this segment. A few of the significant secondary sources associated with the Asia Pacific Medical Device Additives Manufacturing market report are the World Health Organization (WHO), Asia Pacific Centers of Disease Control and Prevention (CDC), Chinese government, Ministry of Health and welfare, Japan and among others. Read the full report: https://www.reportlinker.com/p05989504/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The rebranded Dragon / Penske Autosport team has revealed a striking matte white and chrome red livery for Formula E’s first season as a world championship.
The Portuguese has guided Spurs to the top of the Premier League ahead of this weekend’s return to former club Chelsea
Today Banimmo NV closed a 5-year private placement of Bonds for an amount of EUR 50 million. The bonds, each with a denomination of EUR 100.000, bear a fixed coupon of 4.50% per annum.The bonds will be issued on December 2nd 2020 and will be admitted to trading on Euronext Growth Brussels under ISIN Code BE0002748292.The net proceeds of the bond issue will be used by Banimmo NV to finance the current development projects in Ghent and Brussels and support the growth strategy through further development of the existing portfolio and future acquisitions. They will also contribute to the diversification of the financial resources and the reorganisation of the existing debt.KBC Bank NV acted as sole book runner for this placement.Laurent Calonne, CEO: "Since the entry of Patronale Life in the capital and the appointment of a new management, Banimmo has launched 3 major real estate projects in Ghent, Brussels and Louvain-la-Neuve. These projects, of which one has already successfully been sold, will fully focus on flexible, service-based and sustainable real estate, pursuant to Banimmo’s newly defined mission and strategy that we will unveil in the weeks to come”.For more information, contact:Banimmo SA Laurent Calonne Werner Van Walle Bischoffsheimlaan 33 CEO Chairman of the Board of Directors B-1000 Brussels firstname.lastname@example.org Werner.VanWalle@patronale-life.be T +32 2 710 53 11This press release is available on the website of the company www.banimmo.be On Banimmo Banimmo is an important player in the transformation of tertiary real estate assets and the development of build-to-suit building that respond to the needs and strict criteria of investors-users and tenants. The current real estate portfolio comprises approximately 38,459 m² of developed surfaces and a reserve of ca. 281,000 m² of development potential.Attachment * Banimmo PB_private placement_27 11 2020_ENG_F
and it is expected to grow at a CAGR of 4. 9% during 2019–2027, to reach US$ 6,383. 64 Million by 2027. Outdoor furniture such as chairs, tables, seating sets, dining sets, loungers, daybeds, hammocks, and others are quite popular among both the residential and commercial customers.New York, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asia Pacific Outdoor Furniture Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Material ; Product ; and End User" - https://www.reportlinker.com/p05989505/?utm_source=GNW The outdoor furniture market on a wide scale has been witnessing substantial growth in the recent past. Factors including the rise in consumer spending & traveling trends resulted in a rise in the number of tourists across the world.These factors are mostly observed in tourist spots, beach sides, and hill stations, thereby leading to multiplying counts of motels, hotels, guest houses, resorts, open spaces, and public gardens. The rise in focus towards attractive garden and lounge areas has perpetually driven the demand for aesthetic items such as chairs, tables, and other accessories.It is expected to have a positive impact upon market growth. The shift in consumer spending towards better living backed by rise in per capita and disposable income has augmented the growth of outdoor furniture market. Furthermore, renovations in old residential building along with new constructions have also channelized the demand for the better outdoor furniture facilities such as table, chairs or combination sets. In current era, consumers are looking out for outdoor furniture which offers the same level of comfort as that provided by the indoor furniture which has proliferated the demand for seating sets in the Asia Pacific outdoor garden furniture market. In addition to this, the usage of wood in production of outdoor garden furniture has also gained prominence with the growing focus over sustainability as well as aesthetic appearance. Based on material, the Asia Pacific outdoor furniture market has been segmented into wood, metal, plastics and others.In 2018, the wood segment dominated the market, and the market for the plastic is projected to grow at the highest CAGR during the forecast period. The growth of the plastic segment is primarily attributed to the fact that plastic are wide range of synthetic or semi-synthetic organic compounds that are malleable and so can also be molded into solid objects.Plastics are basically organic polymers with high molecular mass and often contain other substances as well. They are primarily synthetic, and most commonly derived from petrochemicals.However, arrays of variants are prepared from renewable materials, including polylactic acid from corn or cellulosic from cotton linters. In developed economies, approximately a third of plastic is utilized in packaging and roughly the same in buildings in applications, including piping, plumbing, or vinyl siding. Other uses include automobiles (up to 20% plastic), furniture, and toys. Low-density polyethylene (LDPE) is mainly used to prepare outdoor furniture, siding, floor tiles, shower curtains, and clamshell packaging. Asia Pacific includes developed economies such as the China, japan, India, Australia, South Korea, Rest of APAC as a developing nation.The companies involved in the production of outdoor furniture are continuously enhancing the overall business processes to meet the customers demand in the best possible way. Several domestic and international companies have a strong foothold in Asia Pacific.In the region, the China is a major market for outdoor furniture, followed by India and rest of Asia Pacific, respectively. The demand for outdoor furniture in Asia Pacific has surged owing to the adoption of better standards of living along with higher income level in the western parts.An upsurge in the demand for outdoor gardening and outdoor & rooftop seating has created a fruitful growth of the market in the Asia Pacific region. Rising disposable income, urbanization, and better lifestyles, further boosting the market. The high purchasing power of the consumers results in rising demand for outdoor furniture. The manufactured outdoor furnitures are marketed all across Asia Pacific. The Asia Pacific manufacturers at the nascent stage exported to other parts of the world. Besides this, the growing application of outdoor furnitures in residential and commercial applications also supports the market for outdoor furniture in the Asia Pacific region. Agio International Company Ltd., Ashley Home Stores, Ltd., Barbeques Galore, Brown Jordan, Century Furniture LLC, Inter Ikea Systems B.V. and Keter Group are among the major players operating in the Asia Pacific outdoor furniture market. The COVID-19 pandemic first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe.As of August 2020, USA, Brazil, India, Russia, South Africa, Mexico, Spain and UK are among the worst-affected countries in terms confirmed cases and reported deaths. The pandemic has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns.Shutdowns of consumer goods industry and disruptions in supply chains due to lockdown of countries has created a strain on the supplies of the various products offered by this industry. India has the highest number of confirmed cases of COVID-19 infection among all Asia Pacific countries.The government of Asia Pacific is taking possible steps to reduce its effects by announcing lockdown, and thus, impact the revenue generated by the market. The Airports Council International (ACI) Asia-Pacific warned that the prolonged duration of the COVID-19 would drastically impact the region’s airports’ connectivity and economic sustainability, significantly restricting them from achieving previously forecasted growth prospects. Such closures are anticipated to negatively impact market growth in the coming period. Till now, India has the highest number of COVID -19 confirmed cases. The overall Asia Pacific outdoor furniture market size has been derived in accordance to both primary and secondary source.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants and commentators to validate data, as well as to gain more analytical insights into the topic. The participants who typically involved in the process include industry expert such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the Asia Pacific outdoor furniture market. Read the full report: https://www.reportlinker.com/p05989505/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The hot tech stock is now hitting all-time highs following its hot initial public offering in September.
Everything you need to know ahead of Friday night’s game
Everything you need to know ahead of Friday night’s game
The coronavirus is clouding "Black Friday" much as it has overshadowed 2020 in general, but some leading experts still expect strong overall sales even as shopping patterns are altered.
November 27, 2020, 17h45Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions (Belgian Gazette 12.VI.2007 ) (hereinafter, the “Law”)Under this provision:"[...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as well as, by category, the number of securities conferring the right to vote and voting rights vote, at the latest at the end of each calendar month in which an increase or a decrease in these numbers occurred. On each publication referred to in the first paragraph, the issuer also mentions, if applicable, the total number of bonds convertible into securities conferring the right to vote and rights materialized or not by securities to the subscription of securities conferring the right to vote not yet issued, the total number of voting rights that would result from the exercise of these conversion or subscription rights and the total number of shares without voting rights. "The following information are current as of November 27, 2020:Nature of information Remark Amount of capital (EUR)42.294.182,30 Securities with voting rights =(A)30.133.920This is the basis for calculating the 30% threshold provided in article 5 of the takeover law of April 1, 2007 (Belgian Gazette 26.IV.2007) Shares with voting rights30.133.920 Shares with loyalty voting right (section 28 of the articles of association) =(B)8.120.827 Existing voting rights =[A-B+(B*2)]38.254.747This is the denominator under which must be calculated the quota of voting rights that can give rise to notification in accordance with article 6 of the Law Bonds convertible into shares (CB)0 Voting rights that would result of CB conversion0 Subscription rights (warrants) issued and exercisable187.108 Voting rights that would result of warrant conversion187.108 Subscription rights (stock options) issued (and exercisable from January 1, 2024 except in exceptional cases provided for in the Plan)Max 500.000SOP Plan 2020 Voting rights that would result of stock option conversionMax 500.000SOP Plan 2020 Statutory and legal thresholds (section 35 of the articles of association)1%, 2%, 3%, 4%, 5%, 7.5%, 10%, 15%, etc. by increments of 5%These are the thresholds under which the crossing, whether upward or downward (including passive crossing), gives rise to notification in accordance with section 6 or 18, §2, of the Law. Contact person for threshold crossing notifications: firstname.lastname@example.org.Shares endowed with the right to vote in loyalty: registered shares recorded in the share register for at least two consecutive years in the name of their holder (section 28 of the articles of association, in accordance with section 7:53 of the Companies and Associations Code).Following the introduction of the loyalty voting right by decision of the general meeting of March 10, 2020, the calculation method used by IBA to determine the number of shares with the loyalty voting right at any time is the LIFO method (last in, first out), namely: for the same registered shareholder, the shares which the latter most recently acquired are the first shares which will be deducted from his “basket” of registered shares if he transfer shares thereafter.Statutory ceiling (section 7, paragraph 1, of the articles of association: “No shareholder may, with companies and persons related to him, participate in the voting at general meetings for a number of votes exceeding 35% of the votes attached to all of the shares with voting rights issued by the company”): currently 35% of 38.254.747, i.e. 13.389.161 votes.ISIN Code : Euronext Brussels BE0003766806______________________ Attachment * 20201127-Communique article 15 Loi transparence EN
2300 Meadovale Boulevard Mississauga, Ontario On-Site Cafe Concept Rendering Upgraded Atrium Concept Rendering Upgraded Atrium and Common Areas Concept RenderingTORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Crown Realty Partners (“Crown”) announced the sale of 2300 Meadowvale Boulevard, Mississauga to an institutional buyer for $75.5 million or $315 psf. The property was originally acquired by Crown on behalf of its fourth value-add fund, CR IV LP, in June 2017 with a two-year leaseback from the original owner. Upon acquisition, Crown initiated the repositioning and marketing program for this corporate campus including large-scale capital upgrades to the common areas, amenities and parking facilities. Within 12 months, Crown completed a long-term lease for the entire property as the GTA office hub for one of the world’s largest healthcare companies. Located on 23 acres within the Meadowvale Business Park in the City of Mississauga, the three-storey 240,000 sq. ft. building is easily accessible by the 400 series highways, public transit and the Meadowvale Go Station. The campus offers sprawling floorplates and plenty of greenspace, including ravines and on-site walking trails.“This is a high-quality and stable asset in Meadowvale, one of the most prominent suburban office markets in the GTA,” said Emily Hanna, Partner, Investments at Crown. “The custom build-outs and extensive tenant improvements demonstrate the tenant’s long-term commitment to the property, which helps guarantee a stable income for the new owner.” The buyer has chosen to retain Crown to continue to oversee the management of the property.Crown is actively seeking additional value-add investments and has begun fundraising for its fifth value-add fund, CR V LP.About Crown Realty Partners Crown is an integrated commercial real estate investment and management firm focused on value-add opportunities across Canada, with over two billion dollars of real assets under management. Crown has a well-established track record, an experienced team and takes a hands-on approach to provide superior returns for investors and better workplaces for tenants. For further information, please contact: Emily Hanna Partner, Investments Crown Realty Partners 647.729.2609 email@example.comPhotos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f9475a73-790e-43e1-87dc-9d4e65e877a2https://www.globenewswire.com/NewsRoom/AttachmentNg/6c652608-9ba8-4afe-89bc-24ac87307c76https://www.globenewswire.com/NewsRoom/AttachmentNg/56bafd7e-830a-41df-94e2-fae58cfe9531https://www.globenewswire.com/NewsRoom/AttachmentNg/c3f1a898-e960-410b-9b18-db2081e00ee6
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)Louvain-la-Neuve, Belgium, November 27, 2020, 17.45Summary of the notificationIBA (Ion Beam Application), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on November 27, 2020.In its notification, Paladin Asset Management Investmentaktiengesellschaft mit TGV has notified, that following an acquisition of IBA shares with voting rights, its total holding in IBA SA has crossed upwards the 2% threshold.Content of the notification * Reason for the notification: Acquisition or disposal of voting securities or voting right * Notification by : A parent undertaking or a controlling person * Persons subject to the notification requirement: Paladin Asset Management Investmentaktiengesellschaft mit TGV, Lister Straße 6, 30163 Hannover / Germany Marcel Maschmeyer * Date on which the threshold is crossed: 26/11/2020 * Threshold crossed (in %): 2% * Denominator: 38.254.747 * Notified details: (extract of the received notification form) A) Voting rightsPrevious notificationAfter the transaction of voting rights of voting rights% of voting rights Holders of voting rights Linked to securitiesNot linked to the securitiesLinked to securitiesNot linked to the securities Marcel Maschmeyer0000.00%0.00% Paladin Asset Management Investmentaktiengesellschaft mit TGV400.000768.76502,01%0.00% Subtotal0768.765 2,01% TOTAL768.76502,01%0,00% B) Equivalent financial instrumentsAfter the transaction Holder of equivalent financial instruments Type of financial instrumentExpiration dateExercise period or date of voting rights that may be acquired if the instrument is exercised% of voting rightsSettlement TOTAL 00.00% TOTAL (A & B) of voting rights%of voting rights 768.7652,01% * Full chain of controlled undertakings through which the holding is effectively held Marcel Maschmeyer controls Paladin Asset Management Investmentaktiengesellschaft mit TGV. * Additional InformationPaladin Asset Management Investmentaktiengesellschaft mit TGV is the investment management company that can exercise the voting rights at its discretion, in the absence of specific instructions.For further information, please contact:IBAElodie Jaumain Paralegal +32 10 203 firstname.lastname@example.orgAbout IBAIBA (Ion Beam Applications) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com Attachment * 20201127transparencyPaladin_EN(au-dessus2%)
PRESS RELEASE Paris, November 27, 2020 – 5.45 p.m.YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATIONSuccess of the partial buyback of the Undated Deeply Subordinated BondTouax SCA announces today that it has bought back and canceled part of the Undated Deeply Subordinated Bond issued in August 2013, November 2013 and May 2014, for a nominal amount of 24.2 million euros. The outstanding amount of the bonds stands at 26.6 million euros.This operation will enable to optimize the capital structure of the Group and to lower the related costs.Fabrice and Raphaël Walewski, managing partners of Touax Group commented: “The strategic refocusing initiated since 2018 around the long-term rental business of environmentally-friendly transport equipment has allowed a return to growth and profit over the first half of 2020.The capital increase of Touax Rail for 81.9 million euros achieved at the end of September 2020 significantly strengthened the capital of the Rail division and the group and thus accelerates its development.Touax Group’s shareholder value creation strategy continues with initiatives to lower the cost of its debt, of which this operation is part. We would like to thank the investors who have supported us over the past 6 years on this instrument which has enabled them to generate an average annual return of 7.95%.”Touax was advised by the firm White & Case (legal advisor) and the company Octo Finances (Dealer Manager), SGSS and Lucid were respectively tender agent and information agent.UPCOMING EVENTS * February 26, 2021: 2020 Revenue from activities * March 24, 2021: 2020 annual results – SFAF presentation * March 26, 2021: Conference call to present the annual results TOUAX Group leases out tangible assets (freight railcars, river barges and containers) on a daily basis worldwide, both on its own account and for investors. With nearly €1.1bn in assets under management, TOUAX is one of the leading European players in the leasing of such equipment.TOUAX is listed on the EURONEXT stock market in Paris - Euronext Paris Compartment C (ISIN code: FR0000033003) - and is listed on the CAC® Small, CAC® Mid & Small and EnterNext©PEA-PME 150 indices.For further information please visit: www.touax.com Contacts: TOUAX ACTIFIN Fabrice & Raphaël WALEWSKI Ghislaine Gasparetto email@example.com firstname.lastname@example.org www.touax.com Tel: +33 1 56 88 11 11 Tel: +33 1 46 96 18 00 Attachment * EN TOUAX PR TSSDI 27 11 2020
The market is estimated to grow with a CAGR of 4. 4% from 2020–2027. The growth of the market is attributed to some key driving factors such as increasing investment in R&D; by market players and high rise in pharmaceutical and biotechnology industries.New York, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asia Pacific Pipette Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type ; Category ; Channel ; Volume ; Application and Country" - https://www.reportlinker.com/p05989506/?utm_source=GNW However, high cost of R&D and devices is expected to obstruct the growth of the market to a certain extent during the forecast period. Pipettes are laboratory tools commonly used in biotechnology, pharmaceutical, and chemical laboratories to transport specific volume of liquids or samples.Various types of pipette designs such as electronic pipetting and ultra-light pipettes are available in the market. The pipettes help in accurately measuring the liquids for various biology experiments, pharmaceutical applications, and others.These devices help in preventing contamination and easy handling of liquids during laboratory procedures. Two types of pipettes commonly used are glass pipettes that are excellent in chemical resistance, and plastic pipettes that are convenient in preventing contamination. Rise in investments in R&D by market players contribute to the growth of the pipette market across the Asia Pacific. As per the Invest India statistics for the year 2018, it is stated that the Indian Biotechnology industry is likely to create opportunities worth approximately US$ 80.8 million. Also, the country has 14 ongoing biotechnology projects across the country. Chong Kun Dang Pharmaceutical, Samsung Biologics, SK Chemicals, Hanmi Pharm, DaewoongPharma, and Ildong Pharmaceutical are among the major pharmaceutical players in South Korea. Therefore, a rising number of pharmaceutical and healthcare companies is expected to grow drug development activities. The companies and organizations in the country are supporting for the research and development activities for drug development. For instance, in February 2018, Korea Pharmaceutical and Bio-Pharma Manufacturers Association has launched AI Drug Development Support Center, which aims to prepare a path for new drug development. Thus, integrating the latest technologies are leading to the automation in the sector, and hence it is expected that the country is likely to create good growth opportunity for pipettes market during the forecast period. Based on type, the pipette market is segmented into air displacement pipette, and positive displacement pipette. The air displacement pipette segment held a larger share of the market in 2019; whereas, the positive displacement pipette segment is anticipated to register a higher CAGR in the market during the forecast period. Based on category, the pipette market is segmented into manual and electronic. The manual segment held a larger share of the market in 2019; whereas, the electronic segment is anticipated to register a higher CAGR in the market during the forecast period. Based on channel, the pipette market is segmented into single channel and multi-channel (8-channel, 12-channel, and others). The multi-channel segment held a larger share of the market in 2019 and is anticipated to register a higher CAGR in the market during the forecast period. Based on volume, the pipette market is segmented into adjustable volume and fixed volume. The adjustable volume segment held a larger share of the market in 2019 and is anticipated to register a higher CAGR in the market during the forecast period. Based on application, the pipette market is segmented into pharmaceutical laboratories, biotech laboratories, food & beverage, forensic laboratories, and others. The pharmaceutical laboratories segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. Some of the major primary and secondary sources for Asia Pacific pipette market included in the report are US Food and Drug Administration (FDA), Invest India, and others. Read the full report: https://www.reportlinker.com/p05989506/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The Indian economy has entered into recession driven by the coronavirus pandemic, with data showing a contraction of 7.5 per cent of GDP in the third quarter.
Despite industry data showing Clorox (NYSE: CLX) sales are accelerating both sequentially and year over year, an analyst is maintaining her price target of $268 per share on the household products maker. Shares of Clorox are down 16% from the all-time high they hit in August, but they remain 30% above where they started 2020, and rising cases of COVID-19 suggest sales will accelerate further. Clorox reported organic sales shot 27% higher in its fiscal 2021 first quarter and profits doubled. Not only were sales of its disinfecting wipes soaring, but consumers were still choosing to cook more at home than going out to eat.
It was a day late, but the stock market gave thanks on Friday morning with solid gains. As we've seen a lot during 2020, the Nasdaq Composite (NASDAQINDEX: ^IXIC) led the way higher, rising on hopes that 2021 will bring a full recovery from the yearlong COVID-19 pandemic and the economic devastation that has been seen around the world. As of approximately 11 a.m. EST, the Nasdaq Composite was higher by more than 1%, pushing it further into all-time record territory.
Lewis Hamilton set the fastest time on the opening day of Bahrain Grand Prix practice at Sakhir for Mercedes on Friday, with Red Bull’s Max Verstappen best of the rest.